Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Purple Biotech (PPBT) EPS (Weighted Average and Diluted) (2022 - 2025)

Purple Biotech has reported EPS (Weighted Average and Diluted) over the past 1 years, most recently at -$41.31 for Q4 2022.

  • Quarterly EPS (Weighted Average and Diluted) changed N/A to -$41.31 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$41.31 through Dec 2022, changed N/A year-over-year, with the annual reading at $0.03 for FY2025, 99.46% down from the prior year.
  • EPS (Weighted Average and Diluted) was -$41.31 for Q4 2022 at Purple Biotech.
  • Over five years, EPS (Weighted Average and Diluted) peaked at -$41.31 in Q4 2022 and troughed at -$41.31 in Q4 2022.